These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7691404)

  • 1. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
    Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 splice variants: expression during lymphocyte activation and tumor progression.
    Pals ST; Koopman G; Heider KH; Griffioen A; Adolf GR; Van den Berg F; Ponta H; Herrlich P; Horst E
    Behring Inst Mitt; 1993 Aug; (92):273-7. PubMed ID: 7504454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.
    Brooks L; Niedobitek G; Agathanggelou A; Farrell PJ
    Am J Pathol; 1995 May; 146(5):1102-12. PubMed ID: 7538265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
    Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
    Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 isoforms in metastatic cancer.
    Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
    Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
    Hofmann M; Rudy W; Zöller M; Tölg C; Ponta H; Herrlich P; Günthert U
    Cancer Res; 1991 Oct; 51(19):5292-7. PubMed ID: 1717145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
    Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
    Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of the expression of CD44v2 in colorectal cancer.
    Haruyama K; Matsumura Y; Moriya Y; Kakizoe T; Ochiai A; Kawaguchi M; Saito T
    Anticancer Res; 1999; 19(5C):4421-8. PubMed ID: 10650786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.